Adverse reactions following first three doses of the BNT162b2 mRNA COVID-19 vaccine: A prospective cohort study on relationships with individual characteristics and previous experience of adverse reactions

Adverse reactions following first three doses of the BNT162b2 mRNA COVID-19 vaccine: A prospective cohort study on relationships with individual characteristics and previous experience of adverse reactions

A clear consensus on the factors contributing to adverse reactions following the mRNA COVID-19 vaccine has yet to be reached. Therefore, the present study investigated adverse reactions following the first three doses of the BNT162b2 mRNA COVID-19 vaccine and examined associated factors, including p...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayako Konishi, Wakaba Fukushima, Tomoka Matsuura, Satoko Ohfuji, Tetsuo Kase, Kyoko Kondo, Kazuhiro Matsumoto, Asae Suita, Emiko Mukai, Ayane Kasamatsu, Yasutoshi Kido, Yu Nakagama, Yuko Nitahara, Yukihiro Kaneko, Akira Kaneko, Etsuko Nakagami-Yamaguchi, Hiroshi Kakeya, Yoshio Hirota
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
SARS-CoV-2
mRNACOVID-19 vaccine
BNT162b2
adverse reactions
adverse effects
vaccine safety
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2518646
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items